Top Tweets for #AltisSIS
The #AltisSIS 522 study was purposefully designed to be more reflective of real-world clinical practices. Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
The #AltisSIS is the ONLY SIS with bidirectional post-deployment adjustability, allowing for precise placement for each patient #ConsistentResults See Coloplast’s commitment to #MakingLifeEasier for women suffering from #SUI here: https://t.co/vovPsZc1GQ
Our confidence in the #AltisSIS is demonstrated by directly comparing to competitive, market-leading full-length transobturator and retropubic slings, and validated by similar results at 12-months. Learn more about what makes the Altis 522 study unique: https://t.co/vovPsZc1GQ
Coloplast is #CommittedToResearch and providing subsequent reports of the #AltisSIS at 24- and 36-months. View the 12-month results here: https://t.co/vovPsYUqig
#AltisSIS is the first and only 522 study to include single incision and full-length transobturator AND retropubic slings! Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
Nearly 10 years after market introduction, the #AltisSIS is the ONLY SLING to have a premarket IDE and several independent studies confirming similar cure rates and safety profiles to the 522 12-month results. View the 12-month results here: https://t.co/vovPsZc1GQ
Both #AltisSIS and market-leading full-length transobturator and retropubic slings demonstrated high objective and subjective cure rates at 12-months #GoldStandardComparisons View the Altis 522 12-month results here: https://t.co/vovPsZc1GQ
The #AltisSIS 522 study is a postmarket, prospective, multicenter, nonrandomized cohort performed at 23 hospitals in the US and Canada. View the 12-month results here: https://t.co/vovPsZc1GQ
More #AltisSIS patients received local anesthesia and were treated in an outpatient setting. See Coloplast’s commitment to #MakingLifeEasier for women suffering from #SUI here: https://t.co/vovPsZc1GQ
#AltisSIS was purposefully designed, and studied, to treat women suffering from SUI. Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
At 12-months of follow-up, safety and efficacy appear similar between #AltisSIS and standard full-length transobturator and retropubic midurethral slings #GoldStandardComparisons View the Altis 522 12-month results here: https://t.co/vovPsZc1GQ
Did you know that ALL commercially available full-length retropubic and transobturator slings were allowed in the comparator group in the #AltisSIS 522 study? Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
The #AltisSIS is a fully adjustable single incision sling, purposefully designed to mimic the PUL and is the ONLY SLING to have an IDE and 522! Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
The #AltisSIS 522 study allowed all competitive retropubic and transobturator slings in the comparator arm. Learn more about the Altis 522 study design here: https://t.co/vovPsZc1GQ
At 12-months, 24-hour pad weight success, negative CST, PGI-I, UDI-6, and IIQ-7 were similar between #AltisSIS and full-length MUS #ConsistentResults View the Altis 522 12-month results here: https://t.co/vovPsZc1GQ
The same rigorous & robust testing methods used in the #AltisSIS IDE study, such as 24-hr pad weight testing & a full range of QoL questionnaires, are also included in the 522 study. Learn more about what makes the Altis 522 study unique here: https://t.co/vovPsZc1GQ
The #AltisSIS 522 study was designed to collect a full range of objective and subjective outcome measurements, included competitive full-length retropubic and transobturator slings, and did not exclude ISD patients. View the Altis 522 12-month results here https://t.co/vovPsZc1GQ
Surgical intervention was based on surgeon expertise and shared decision-making with patients, making the #AltisSIS more reflective of real-world clinical practices. See Coloplast’s commitment to #WomensHealth and treating #SUI here: https://t.co/vovPsZc1GQ
90.4% of #AltisSIS patients reported "Very Much Better" or "Much Better" at 12-months in the 522 study… exactly the same at 24-months in the IDE! #ConsistentlResults View the 522 12-month results here: https://t.co/vovPsZc1GQ
Last Seen Hashtags on Sotwe
รับงานพนมสารคาม
Seen from Thailand
4i
Seen from Australia
jalurROW
Seen from United States
BACKTOTHEMEMORYS
Seen from United States
MayorsGivingTreeAppeal
Seen from United States
tamil aunty
Seen from India
끝이안보임
Seen from United States
tango #buzzcast
Seen from United States
تونس
Seen from Netherlands
Blackedhentai
Seen from Italy
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers